Report: Are VCs fleeing med-tech?

October 7, 2011 by MassDevice staff

Investors move away from medical devices and into areas less regulated by the FDA, National Venture Capitalists Assn. survey finds.

National Venture Capital Association logo

Investors are paring their stakes in health care and shifting capital into projects with less regulatory risk, according to a new survey by the National Venture Capitalists Assn.'s Medical Innovation & Competitiveness Coalition.

Investors are running away from med-tech and pharma in particular, with 61 of the VCs pointing to regulatory challenges as the prime reason for the shift, the survey found.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.